Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
About Tysabri
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury.
Secukinumab (AIN457) showed superiority over Enbrel® in clearing skin, according to pivotal Novartis Phase III psoriasis results at EADV
Association between pathological and MRI findings in multiple sclerosis.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
Microglia: Architects of the Developing Nervous System.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.

Pages